1.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CDR0000067957, ALLOS-RSR13RT-009, NCT00005887
|
|
2.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: RT-016, NCT00083304
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NABTT-9806, JHOC-NABTT-9806, NCT00005855
|
|
4.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: NABTT-9707, ALLOS-RSR13RT-007, JHOC-NABTT-9707
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-9711049, ALLOS-RSR13RT-008, NCI-G99-1611
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CDR0000067445, ALLOS-RSR13RT-010, VU-VCC-THO-9828, NCT00004202
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: NABTT-9606, JHOC-NABTT-9606, NCI-T96-0085
|